PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 114 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 45.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $204,000 | +2.5% | 79,483 | 0.0% | 0.00% | – |
| Q4 2020 | $199,000 | +26.8% | 79,483 | +4.8% | 0.00% | – |
| Q3 2020 | $157,000 | -28.6% | 75,873 | +6.7% | 0.00% | – |
| Q2 2020 | $220,000 | +35.8% | 71,126 | 0.0% | 0.00% | – |
| Q1 2020 | $162,000 | -36.2% | 71,126 | +1.2% | 0.00% | – |
| Q4 2019 | $254,000 | +4.5% | 70,302 | -1.3% | 0.00% | – |
| Q3 2019 | $243,000 | -27.5% | 71,258 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $335,000 | +22.7% | 71,258 | -12.4% | 0.00% | 0.0% |
| Q1 2019 | $273,000 | +26.4% | 81,349 | 0.0% | 0.00% | – |
| Q4 2018 | $216,000 | -51.5% | 81,349 | +2.4% | 0.00% | -100.0% |
| Q3 2018 | $445,000 | +10.4% | 79,464 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $403,000 | -3.1% | 79,464 | +30.3% | 0.00% | 0.0% |
| Q1 2018 | $416,000 | -2.1% | 60,990 | +8.3% | 0.00% | 0.0% |
| Q4 2017 | $425,000 | +37.5% | 56,325 | +4.9% | 0.00% | 0.0% |
| Q3 2017 | $309,000 | +0.3% | 53,717 | -11.6% | 0.00% | 0.0% |
| Q2 2017 | $308,000 | – | 60,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |